Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Standard of Care × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 75 Neoplasms 66 Prostatic Neoplasms 51 Colorectal Neoplasms 43 Lung Neoplasms 38 Carcinoma, Non-Small-Cell Lung 28 Pancreatic Neoplasms 21 Hematologic Neoplasms 21 Neoplasm Metastasis 19 Head and Neck Neoplasms 19 Urinary Bladder Neoplasms 15 Ovarian Neoplasms 15 Multiple Myeloma 15 Stomach Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 11 Motor Activity 11 Leukemia, Myeloid, Acute 11 Glioblastoma 10 Uterine Cervical Neoplasms 9 Triple Negative Breast Neoplasms 9 Gastrointestinal Neoplasms 9 Colonic Neoplasms 9 Melanoma 8 Hematopoietic and Lymphatic System Neoplasm 8 Glioma 8 Esophageal Neoplasms 8 Carcinoma, Renal Cell 8 COVID-19 8 Anxiety Disorders 8 Anatomic Stage I Breast Cancer AJCC v8 8

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Melphalan 9 Interleukin-2 9 Cyclophosphamide 9 CTLA-4 Antigen 8 tebentafusp 7 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 Ranibizumab 6 montanide ISA 51 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Blood Specimen Collection 5 Bevacizumab 5 fludarabine phosphate 4 fludarabine 4 aldesleukin 4 aflibercept 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Biopsy 4 trametinib 3 sotrastaurin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05266430 2023-08-09

IL

Aura Biosciences

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡